Skip to main content

Table 1 Therapeutic angiogenic effect of ASCs in animal IHD models

From: Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases

Animal model

Cell source

Delivery

Outcome

Underlying mechanisms

Pig MI

Autologous ASCs

Intracoronary injection

LVEF↑, LV wall thickness↑,

vascular density↑

Differentiation into ECs and SMCs

Rat MI

Rat ASCs

Intramyocardial injection

LVEF↑, LVFS↑,

capillary vessels↑

Differentiation into ECs

Rat MI

Allogeneic SVF cells

Intramyocardial injection

LVEF↑, LVFS↑, ESD↓, ESV↓,

capillary density↑

Differentiation into ECs

Paracrine secretion: VEGF, HGF, MCP-1, TIMP1, TIMP4

Rabbit MI

Rabbit ASCs

Intramyocardial injection

LVEF↑, peak + dP/dt↑, scar size↓,

capillary density↑

Differentiation into cardiomyocytes

Mouse MI

Mouse ASCs

Intramyocardial injection

LVEF↑, LVEDV↑, LVESV↑,

capillary density↑

Differentiation into cardiomyocytes

Rat MI

Rat ASCs

Intramyocardial injection

LVEF↑, LV wall thickness↑,

capillary density↑,

Percentage of viable myocardium↑,

Paracrine secretion: VEGF

Nude rat MI

Human ASCs

Intramyocardial injection

LVEF↑, LVFS↑, EDV↓, ESV↓

LV wall thickness↑, infarct size↓,

capillary density↑

Paracrine secretion: VEGF, HGF, β-NGF

Nude rat MI

Human ASCs

Intramyocardial injection

LVEF↑, LVFS↑, infarct size↓,

capillary density↑

Paracrine secretion: VEGF, bFGF, SDF-1α

Pig I/R

Autologous ASCs

Intramyocardial injection

LVEF↑, ESD↓, ESV↓, EDV↓,

capillary density↑

Regulation of MMP/TIMP system

Rat MI

3D-cultured human ASCs

Intramyocardial injection

Infarct size↓, cardiomyocyte apoptosis↓,

Capillary density↑

Differentiated into ECs and VSMCs

Paracrine secretion: VEGF

Rat MI

Rat SVF cells

laid onto the epicardium

Relative infarcted volume↓,

coronary vascular density↑,

perfused vessels↑

Paracrine secretion: VEGF

Pig I/R

Allogeneic ASCs

Intracoronary injection

Vascular density↑

Differentiation into VSMCs, ECs, and cardiomyocytes

Paracrine secretion: VEGF

  1. ↑ increase, ↓ decrease, ASC adipose-derived stem cell, IHD ischemic heart disease, I/R ischemia/reperfusion, SVF stromal vascular fraction, SMC smooth muscle cells, LVFS left ventricular fractional shortening, ESD end-systolic dimension, ESV end-systolic volume, EDV end-diastolic volume, bFGF basic fibroblast growth factor, EC endothelial cell, EF ejection fraction, HGF hepatocyte growth factor, LV left ventricular, MI myocardial infarction, MMP matrix metalloproteinase, TIMP tissue inhibitor of matrix metalloproteinase, VEGF vascular endothelial growth factor